Status:

COMPLETED

The Effect of Narrative Exposure Therapy Intervention on Post-traumatic Stress Dissorder and Personal Recovery in Refugees and Asylum Seekers of Sindiane Programme

Lead Sponsor:

Assistance Publique Hopitaux De Marseille

Conditions:

Post-traumatic Stress Disorder (PTSD)

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Displaced people, like refugees or asylum seekers, have high rate of potentially traumatic events. PTSD is one of the most common psychiatric trouble in this population. It requires specialized suppor...

Detailed Description

Methods and design Forty-six participants with a diagnosis of PTSD disorder within the SINDIANE program will be recruited. A prospective single-blind randomized clinical trial will be conducted compar...

Eligibility Criteria

Inclusion

  • Woman over 18
  • Refugee or asylum seeker (habing applied to OFFPRA or with a residence permit)
  • Belonging to the SINDIANE community project
  • Having been exposed to at least one traumatic event (according to the DSM 5 definition validated by a doctor)
  • Having a PCL5 score greater than 23
  • Agreeing to participate in the study with an informed consent signed by the subject after explanations given by the investigating psychiatrist
  • Patient affiliated to a social security health care
  • Patient able to read and write arabic or french

Exclusion

  • Be under the age of 18
  • Be included in another intervention research
  • Presence of severe mental retardation or dementia according to DSM5
  • Persons benefiting from special protection : under article L3212-1 and L3213-1 of the Public Health Code
  • Persons referred to in articles L1121-5 to L1121-8 of the CSP
  • Existence of a high suicide risk assessed by the R.U.D.
  • Patient subject to a compulsory care measure (Law n°2011-803 of july 5, 2011 relating to the rights and protection of persons subject to psychiatric care and the terms of care)
  • Patient refusing to sign the consent or unable to receive the information necessary to give informed consent

Key Trial Info

Start Date :

November 22 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 23 2024

Estimated Enrollment :

46 Patients enrolled

Trial Details

Trial ID

NCT05407337

Start Date

November 22 2022

End Date

April 23 2024

Last Update

August 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assistance Publique Hôpitaux Marseille

Marseille, Bouches-du-Rhône, France, 13354